Regencell Bioscience Holdings (RGC) Retained Earnings (2020 - 2025)

Regencell Bioscience Holdings has reported Retained Earnings for 6 years, with the latest figure at -$30.5 million in Q4 2025.

• For the quarter ending Q4 2025, Retained Earnings changed N/A year-over-year to -$30.5 million; the trailing twelve-month figure through Dec 2025 stood at -$30.5 million (changed N/A YoY), and the FY2025 full-year result was -$25.2 million, down 16.58% from the prior year.
• Retained Earnings for Q4 2025 stood at -$30.5 million, down from -$25.2 million in the prior quarter.
• The five-year high for Retained Earnings was -$4.0 million in Q2 2021, with the low at -$30.5 million in Q4 2025.
• Historically, Retained Earnings has averaged -$18.3 million across 5 years, with a median of -$19.5 million in 2023.
• Annual changes were most pronounced in 2022 — Retained Earnings slumped 186.24% — and 2025, when it declined 16.58%.
• Regencell Bioscience Holdings' Retained Earnings stood at -$4.0 million in 2021, then sank by 186.24% to -$11.4 million in 2022, then tumbled by 51.3% to -$17.3 million in 2023, then dropped by 24.84% to -$21.6 million in 2024, then slumped by 41.18% to -$30.5 million in 2025.
• The last three Retained Earnings figures came in at -$30.5 million (Q4 2025), -$25.2 million (Q2 2025), and -$21.6 million (Q2 2024), per Business Quant data.